Has Timothy Jochen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $80,822 in general payments to Timothy Jochen, MD across 315 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Jochen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Jochen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Jochen, MD

Procedural Dermatology · Rancho Mirage, CANPI 1083748461

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $75,233 of the $80,822 with a category attached, or 93.1%. AbbVie accounts for 95.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $45,363 and has fallen 94.1% since, to $2,674 in 2025.

$80,822in general payments, 2019–2025

Across 315 payments — averaging $256.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$78K
Galderma Laboratories, L.p.$785
Novartis$623
Revance Therapeutics, Inc.$545
Pfizer$336
Lilly USA, LLC$171
plus $840 from 13 others

$18,757in research payments, 2019–2025

Across 11 payments — averaging $1705.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$18K
Pfizer$1K

What the payments were for

Speaking & faculty fees$75,23393%
Food & beverage$5,4477%
Education$1410%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	144	$77,522
Galderma Laboratories, L.p.	69	$785
Novartis	31	$623
Revance Therapeutics, Inc.	6	$545
Pfizer	20	$336
Lilly USA, LLC	6	$171
Johnson & Johnson	8	$162
Arcutis Biotherapeutics, Inc.	6	$121
Sun Pharmaceutical Industries Inc.	6	$116
Sanofi	3	$94
Organogenesis Inc.	3	$89
Regeneron Healthcare Solutions, Inc.	4	$83
Incyte Corporation	2	$43
Verrica Pharmaceuticals Inc.	2	$37
Amgen	1	$35
LEO Pharma Inc.	1	$20
UCB, Inc.	1	$19
Strata Skin Sciences, Inc.	1	$18
Apyx Medical Corporation	1	$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DAXXIFY$375
BOTOX$255

How this compares

$80,822 in reported general payments places this provider in the 85th percentile of 108 procedural dermatology providers in California.

See all procedural dermatology providers in California →

Medicare billing

Part B allowed, 2024

$3,453,545

Medicare patients

2,103

Services billed

493,212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	16	$89,375
Doxycycline Hyclate	420	$5,569
Fluorouracil	79	$5,267
Ketoconazole	297	$4,881
Pimecrolimus	21	$4,795
Metronidazole	54	$4,425
Tacrolimus	25	$3,333
Triamcinolone Acetonide	339	$3,098
Calcipotriene	31	$2,874
Fluocinonide	50	$2,143
Mupirocin	233	$1,928
Clobetasol Propionate	44	$1,700
Tretinoin	23	$1,581
ValacyclovirValacyclovir Hcl	125	$1,463
Fluocinolone Acetonide	21	$1,316

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Rancho Mirage

Sam Khalifianla Mesa$3.5M
Sabrina FabiSan Diego$3.1M
Natasha MesinkovskaMission Viejo$499K
Jeanette BlackLos Angeles$492K
Mitchel GoldmanSan Diego$425K
Rebecca FitzgeraldLos Angeles$230K
Suzanne KilmerSacramento$220K
Zakia RahmanStanford$181K
Hrak JalianSanta Monica$160K
Amelia HausauerCampbell$117K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →